Skip to content
OpenCapital
Get started

Bruker BRKR Bsi Calid — Operating Income

Other segment segments

Adjustments And Reconciling Items
$74.1M—
Bsi Biospin
$28.8M-22.4%
Bsi Nano
$14.4M-37.7%
Energy And Supercon Technologies
$7.6M+8.6%

Similar metrics at other companies

Charles River Laboratories logo
CRLDSA — Operating Income (Loss)
$103.88M+10.6%
Charles River Laboratories logo
CRLSegment operating income — Operating Income (Loss)
$200.49M+55.5%
Rambus logo
RMBSOperating Segments — Segment Operating Income Loss
$18.16M+15.3%
Bentley Systems, Incorporated logo
BSYReportable Segment — Operating Income (Loss)
$126.26M+9.6%
BridgeBio Pharma logo
BBIOReportable Segment — Operating Income (Loss)
-$105.96M-1.5%
BridgeBio Pharma logo
BBIOReportable Segment Aggregation Before Other Operating — Operating Income
-$134.28M+23.5%

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's bsi calid — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's bsi calid — operating income?
Bruker (BRKR) reported bsi calid — operating income of $62.6M in Q1 2026.
How has Bruker's bsi calid — operating income changed year-over-year?
Bruker's bsi calid — operating income increased by 1.8% year-over-year, from $61.5M to $62.6M.
What is the long-term trend for Bruker's bsi calid — operating income?
Over 4 years (2021 to 2025), Bruker's bsi calid — operating income has grown at a 3.7% compound annual growth rate (CAGR), from $227.2M to $262.5M.
What does bsi calid — operating income mean?
The profit earned from the segment's core business activities.
How do you interpret bsi calid — operating income?
An increase reflects improved operational efficiency and stronger pricing power or cost management.
How does bsi calid — operating income compare across companies?
Standardized as 'Segment Operating Income' or 'Segment Profit'.